/Dr. John Kellie
Dr. John Kellie on Developing a Whole Molecule Approach for Biopharmaceutical Analysis
Dr. John Kellie on Developing a Whole Molecule Approach for Biopharmaceutical Analysis
31 Jul 2016

Dr. John Kellie, Associate Fellow, Bioanalysis, Immunogenicity and Biomarkers, GSK, describes a technique for the quantitation of whole molecule biopharmaceutical candidates using high-resolution mass spec.

Related Scientists

Related Content